secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0000064803-25-000023
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q2 adj EPS $1.81; raises FY25 adj EPS outlook to $6.30-6.40, cuts GAAP view on litigation charges
--------------------------------------------------------------------------------

- Q2 revenue $98.9B (+8.4% YoY); GAAP EPS $0.80 vs $1.41; adj EPS $1.81 vs $1.83.
- Recorded $833M litigation charges and $471M premium deficiency reserve in Medicare Advantage.
- FY25 GAAP EPS guidance lowered to $3.84-3.94 from $4.23-4.43; adj EPS raised to $6.30-6.40 from $6.00-6.20.
- Aetna MBR 89.9% vs 89.6% with premium deficiency impact; medical membership 26.7M down 358k sequentially.
- Agreed to acquire certain Rite Aid prescription files and stores; cash flow from operations guided to at least $7.5B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480325000023/0000064803-25-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480325000023/cvs-20250731.htm
  HTML page:      https://secwatch.observer/filing/0000064803-25-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer